Skip to main content
. 2013 Dec 6;68(2):180–187. doi: 10.1111/ijcp.12315

Table 1.

Patient characteristics, risk categories and lipid parameters

All patients (N = 941) Men (N = 557) Women (N = 379)
Age (years) [mean ± SD] 67.4 ± 9.9 66.5 ± 10.2 68.7 ± 9.4
Caucasian (%) 99.5 99.8 99.1
Family Hx of premature CHD (%) 32.8 34.2 30.2
Current smokers (%) 11.8 14.6 7.9
Hypertension (%) 70.3 70.0 70.6
Systolic BP (mmHg) [mean ± SD] 131.9 ± 13.6 131.8 ± 13.3 132.2 ± 14.2
Diastolic BP (mmHg) [mean ± SD] 78.0 ± 7.9 78.4 ± 7.8 77.5 ± 7.9
Waist circumference (cm) [mean ± SD] 99.7 ± 14.4 103.7 ± 13.3 93.8 ± 14.0
BMI (kg m−2) [mean ± SD] 28.2 ± 5.0 28.4 ± 4.5 28.0 ± 5.7
BMI>30 kg m−2 (%) 28.9 28.4 30.1
CVD (%) 37.6 45.0 26.7
Diabetes mellitus (%) 31.0 34.9 25.1
Metabolic syndrome (IDF) (%) 54.0 56.6 50.5
ESC risk level (2011)
Very high-risk patient (%) 61.0 69.1 48.7
High-risk patient (%) 9.3 8.3 10.8
Moderate-risk patient (%) 20.0 14.7 28.0
Low-risk patient (%) 9.8 7.9 12.4
LDL-C (mg dl−1) [mean ± SD] 99.4 ± 32.1 96.0 ± 30.3 104.1 ± 32.8
HDL-C (mg dl−1) [mean ± SD] 56.3 ± 17.4 52.4 ± 16.2 62.1 ± 17.4
Total cholesterol (mg dl−1) [mean ± SD] 181.5 ± 36.6 175.2 ± 33.9 190.4 ± 37.4
Triglycerides (mg dl−1) [median (IQR)] 117.0 (86.0–161.0) 119.5 (88.0–165.5) 113.5 (85.0–154.0)
Fasting plasma glucose (mg dl−1) [median (IQR)] 100.0 (90.0–116.0) 102.5 (92.0–120.0) 96.0 (88.0–108.0)
HbA1 c [%] in diabetics [median (IQR)] 6.7 (6.2–7.3) 6.7 (6.2–7.4) 6.7 (6.2–7.3)

CHD, coronary heart disease; BP, blood pressure; BMI, Body mass index; CVD, cardiovascular disease; DM, diabetes mellitus; IDF, International Diabetes Federation; Very high risk = pre-existing CVD, diabetes, chronic kidney disease (glomerular filtration rate < 60 ml min−1 1.73 m−2) and/or SCORE ≥ 10%. High risk = markedly elevated single risk factors and/or SCORE ≥ 5% and < 10. Moderate risk = SCORE between ≥ 1% and < 5%. Low risk = SCORE < 1%.